Biopsy samples were graded based on the following criteria: Grade I: Glomerular Cell Cycle inhibitor findings: Slight mesangial cell proliferation and increased matrix. Glomerulosclerosis, crescent

formation, or adhesion to Bowman’s capsule is not observed. Interstitial and vascular findings: Prominent changes are not seen in the interstitium, renal tubuli, or blood vessels. Grade II: Glomerular findings: Slight mesangial cell proliferation and increased matrix. Glomerulosclerosis, crescent formation, or adhesion to Bowman’s capsule seen in <10 % of all biopsied glomeruli. Interstitial and vascular findings: Prominent changes are not seen in the interstitium, renal tubuli, or blood vessels. Grade III: Glomerular findings: Moderate, diffuse mesangial cell proliferation and increased matrix. Glomerulosclerosis crescent formation or adhesion to Bowman’s C646 capsule seen in 10–30 % of all biopsied glomeruli. Interstitial and vascular findings: Cellular infiltration is slight in the interstitium this website except around some sclerosed glomeruli. Tubular atrophy is slight, and mild vascular sclerosis is observed. Grade IV: Glomerular findings: Severe, diffuse cell proliferation and increased matrix. Glomerulosclerosis, crescent formation, or adhesion to Bowman’s capsule seen in >30 % of all biopsied glomeruli. When sites of sclerosis are totaled and converted to global sclerosis, the sclerosis rate is >50 % of all glomeruli. Some glomeruli also show compensatory

hypertrophy. The sclerosis rate is the most important of these indices. Interstitial and vascular findings: Interstitial cellular infiltration and tubular atrophy, as well as fibrosis are seen. Hyperplasia or degeneration may be seen in some intrarenal arteriolar walls. Construction

of the CR rate heat maps Clinical remission was shown as “C” and non-clinical remission as “N.” The CR rate was calculated in each cell. Cells were color coded by the CR rate with >66 % represented by dark blue, 50–65 % by light blue, 50 % by yellow, 33–49 % by orange, <33 % by dark red, and patient number zero by white. The first heat map (Fig. 1) shows the CR rate according to eGFR and urinary protein levels. eGFR, depicted on the vertical axis, was Urocanase divided into eight subgroups with eGFR >90, 80–89, 70–79, 60–69, 50–59, 40–49, 30–39, and 15–29 ml/min/1.73 m2, respectively. Urinary protein was divided into nine subgroups: <0.29, 0.30–0.49, 0.50–0.69, 0.70–0.89, 0.90–1.09, 1.10–1.49, 1.50–1.99, 2.00–2.99, and >3.00 g/day. The second heat map (Fig. 2) has the grade of hematuria on the vertical axis and urinary protein on the horizontal axis. The third heat map (Fig. 3) has the pathological grade on the vertical axis and urinary protein on the horizontal axis. A fourth heat map, with the number of years from diagnosis until TSP on the vertical axis and urinary protein on the horizontal axis, was also constructed (Fig. 4). The number of years from diagnosis until TSP was divided into five subgroups: <1.0, 1.0–2.99, 3.0–5.